ONCOLOGY Staff | Authors

Recap: A Review of Multiple Myeloma Trials That Impact the Standard of Care

May 20, 2022

A panel of experts provides a discussion on treatments for newly diagnosed transplant-eligible and transplant-ineligible relapsed multiple myeloma, and how recent clinical trial data presented at ASH 2021 can be applied to clinical practice.

Recap: Treatment Advances in Chronic GVHD

May 15, 2022

A panel of experts in stem cell transplant and cellular immunotherapy builds a lively discussion on current and emerging treatment options for the management of acute and chronic graft versus host disease.

2022 Genitourinary Cancers Symposium 2-Minute Drill: Experts Review Most Impactful Data

April 20, 2022

Thought leaders Daniel P. Petrylak, MD; Benjamin H. Lowentritt, MD; Alan H. Bryce, MD; and Tanya Dorff, MD, joined CancerNetwork® following the 2022 Genitourinary Cancers Symposium to discuss highlights of the meeting in a game show–style production.

Viability and Future of Maintenance Therapy in Solid Tumors

April 06, 2022

Shilpa Gupta, MD, and Jason R. Brown, MD, PhD, discuss a recently published paper by Grivas et al. (2019) on the use of checkpoint inhibitors for maintenance therapy to prolong the benefits of frontline therapy while minimizing toxicity in solid tumors.